Mayer Arie insider trades

Mayer Arie has filed 9 Form 4s with the SEC that we hold, all for Oramed Pharmaceuticals INC. (ORMP), as Director. Across all of them we count 2 purchases worth $19.5K and 1 sale worth $76.8K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 3,000 shares of Oramed Pharmaceuticals INC. worth $76.8K, dated 2021-11-01. The first filing on our record is dated 2022-01-05 and the latest 2026-01-05.

Oramed Pharmaceuticals INC. (ORMP)

Director · 9 filings · 3 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2021-11-01	S, sale reported on Form 4	3,000	$76.8K	2022-05-10	SEC
2023-04-03	P, purchase reported on Form 4	5,009	$11.1K	2023-04-04	SEC
2023-04-04	P, purchase reported on Form 4	3,800	$8.4K	2023-04-04	SEC

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1796583) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-27 · For informational purposes only, not investment advice.
Privacy · Terms